Chemotherapy-Induced Hair Loss: The Use of Biomarkers for Predicting Alopecic Severity and Treatment Efficacy
Damage to hair follicles following exposure to toxic chemotherapeutics can cause substantial hair loss, commonly known as chemotherapy-induced alopecia (CIA). Preventive therapies remain limited; however, recent advances in the use of scalp cooling technologies have proved successful in preventing o...
Main Authors: | Iain S Haslam, Eleanor Smart |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-04-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.1177/1177271919842180 |
Similar Items
-
Enlarging Alopecic Plaque on the Scalp: A Quiz
by: Yujie Wen, et al.
Published: (2021-01-01) -
Oxidative Stress Biomarkers and Adenosine Deaminase over the Alopecic Area of the Patients with Alopecia Areata
by: Perihan Öztürk, et al.
Published: (2016-04-01) -
Alopecic and aseptic nodules of the scalp with trichoscopic and ultrasonographic findings
by: Anna Isabel Lazaro-Simo, et al.
Published: (2017-01-01) -
Linear alopecic patches in a child: An unusual presentation of trichotillomania
by: Aastha Gupta, et al.
Published: (2019-01-01) -
EXPERIENCE OF SCALP COOLING FOR PREVENTION CHEMOTHERAPY-INDUCED HAIR LOSS
by: I. S. Polezhaeva, et al.
Published: (2017-06-01)